Prognostic value of the bone marrow microvessel density in progressive B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 51, Issue 7, 2010, Pages 1351-1353

  Szmigielska Kapłon, Anna ^a   Lech Maranda, Ewa ^a   Jesionek Kupnicka, Dorota ^a   Gra Tybor, Joanna ^a   Błoski, Jerzy Z ^a   Kasznicki, Marek ^a   Kordek, Radzisław ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD34 ANTIBODY; CLADRIBINE; CYCLOPHOSPHAMIDE; FLUDARABINE; LACTATE DEHYDROGENASE; MITOXANTRONE;

ADULT; AGED; ANEMIA; ANGIOGENESIS; B CELL LEUKEMIA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENSITY; DISEASE COURSE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LEUKEMIA RELAPSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MICROVESSEL DENSITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENT DISEASE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICROVESSELS; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 77954127755     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.486092     Document Type: Letter

References (14)

1. Tung-Ping Poon R, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001;19:1207-1225.
2. Di Raimondo F. Angiogenesis in hematology: a field of active research. Leuk Res 2003;27:571-573.
3. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240-2245.
4. Kay NE, Bone ND, Tschumper RC, et al. B-CLL cells are capable of synthesis and secretion of both pro- and antiangiogenic molecules. Leukemia 2002;16:911-919.
5. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 2000;14:1414-1418.
6. Góra-Tybor J, Boński JZ, Robak T. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia. Eur Cytokine Netw 2005;16:41-46.
7. Molica S, Vacca A, Ribatti D, et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002;100:3344-3351.
8. Molica S, Cutrona G, Vitelli G, et al. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients with early B-cell chronic lymphocytic leukemia. Leuk Res 2007;31:1575-1578.
9. Takagi K, Takada T, Amano H, et al. Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy. J Hepatobiliary Pancreat Surg 2008;15:384-390.
10. Smolej L, Kasparova P. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. APMIS 2008;116:1058-1062.
11. Woowiec D, Wozniak Z, Potoczek S, et al. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia. Anal Quant Cytol Histol 2004;26:263-270.
12. Gora-Tybor J, Blonski JZ, Robak T. Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia. Neoplasma 2002;49:145-148.
13. Szmigielska-Kaplon A, Jesionek-Kupnicka D, Gora-Tybor J, et al. Influence of cladribine on bone marrow angiogenesis in chronic lymphocytic leukemia. Leuk Lymphoma 2007;48: 1042-1044.
14. Molica S, Vacca A, Tucci L, Ribatti D. Reversal of bone marrow angiogenesis in chgronic lymphocytic leukemia following fludarabine therapy. Hematologica 2005;90: 698-700.